We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AZRX market cap is 46.58M. The company's latest EPS is USD -1.1928 and P/E is -2.18.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 8.09M | 0 | 0 | 0 | 0 |
Operating Income | 4.39M | -2.28M | -4.06M | -4.18M | -3.42M |
Net Income | 4.05M | -3.98M | -4.16M | -4.28M | -3.48M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 8.09M | 0 |
Operating Income | -14.74M | -26.43M | -59.06M | -12.68M | -15.77M |
Net Income | -15.18M | -32.67M | -58.54M | -14.97M | -16.1M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 4.65M | 5.44M | 5.53M | 4.33M | 5.93M |
Total Liabilities | 6.93M | 2.7M | 2.82M | 3.45M | 2.65M |
Total Equity | -2.28M | 2.74M | 2.71M | 881k | 3.28M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.9M | 12.92M | 11.79M | 5.44M | 6.88M |
Total Liabilities | 4.29M | 15.57M | 19.61M | 2.7M | 3.28M |
Total Equity | 4.62M | -2.64M | -7.82M | 2.74M | 3.6M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.75M | -22.34M | -2.85M | -5.61M | -8.94M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 10.22M | 15.74M | 3.55M | 5.48M | 10.87M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -14.03M | -11.22M | -32.29M | -22.34M | -12.38M |
Investing | -24k | 88k | -10.32M | N/A | -500k |
Financing | 13.15M | 17.05M | 44.76M | 15.74M | 15.23M |
Market Cap | 46.58M |
Price to Earnings Ratio | -2.18 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.45 |
Price to Book Ratio | 9.74 |
Dividend Yield | - |
Shares Outstanding | 13.5M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.1 (2.85%) |
Company Name | AzurRx BioPharma Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.firstwavebio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions